Novel high‐affinity EGFRvIII‐specific chimeric antigen receptor T cells effectively eliminate human glioblastoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Novel high‐affinity EGFRvIII‐specific chimeric antigen receptor T cells effectively eliminate human glioblastoma

Published:2021-01 Issue:7 Volume:10 Page:
ISSN:2050-0068
Container-title:Clinical & Translational Immunology
language:en
Short-container-title:Clin Transl Immunol

Author:

Abbott Rebecca C,Verdon Daniel J,Gracey Fiona M,Hughes‐Parry Hannah E,Iliopoulos Melinda,Watson Katherine A,Mulazzani Matthias,Luong Kylie,D’Arcy Colleen,Sullivan Lucy C,Kiefel Ben R,Cross Ryan S,Jenkins Misty R

Publisher

Wiley

Subject

General Nursing,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cti2.1317

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment advances in high-grade gliomas;Frontiers in Oncology;2024-04-10

2. Chimeric antigen receptor-immune cells against solid tumors: Structures, mechanisms, recent advances, and future developments;Chinese Medical Journal;2023-08-28

3. Multiple therapeutic approaches of glioblastoma multiforme: From terminal to therapy;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-07

4. Gene Targets of CAR-T Cell Therapy for Glioblastoma;Cancers;2023-04-18

5. Flow Cytometry Identification of Cell Compartments in the Murine Brain;Methods in Molecular Biology;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP